Partnership aims to provide support for people living with chronic conditions via personalised exercise prescriptions.
London. September 4, 2023 – EXI, the Software as a Medical Device (SaMD) that personalises physical activity for people with long-term health conditions, today announced a partnership with NHS Mid and South Essex University Hospitals Group, marking a significant leap forward in healthcare innovation.
“Our team are thrilled to announce our partnership with NHS Mid and South Essex University Hospitals Group. This exciting collaboration reinforces our shared commitment to delivering exceptional healthcare solutions to the NHS and its valued patients”, said Louise O’Mahony – Head of Healthcare Partnerships at EXI.
At the heart of this partnership is an innovative initiative to redefine cardiac rehabilitation services across three leading hospitals. Leveraging state-of-the-art technology and compassionate care, EXI and NHS Mid and South Essex Trust are set to transform the landscape of patient recovery.
Key Features of the Partnership:
Cutting-Edge Cardiac Rehab Services: Through this collaboration, patients will experience a seamless blend of on-site and remote cardiac rehab services, powered by the EXI platform. This innovative approach ensures that patients receive gold standard care, irrespective of their location.
Empowering Patient Journey: The partnership aims to empower 3,000 patients with a Fitbit, that will play a pivotal role in their rehabilitation journey. This technology-driven empowerment will drive progress and enhance overall well-being.
Guided by Expert Health Coaches: As part of the initiative, an in-house health coach will be introduced, driving digital transformation within the cardiac clinical team. This strategic addition underscores the commitment to holistic care and patient-centered rehabilitation.
Optimized Patient Experience: From seamless onboarding to ongoing support, the partnership is dedicated to optimising every aspect of the patient journey. The focus is on providing an unparalleled experience that sets new standards in healthcare excellence.
The partnership signifies a united effort to shape a healthier future for the UK’s healthcare landscape. Stay tuned for inspiring patient stories that will showcase the impact of this partnership, as individuals embrace their cardiac rehab journey from a hospital setting to the comfort of their home and communities.
EXI is Exercise Intelligence – a Software as a Medical Device (SaMD), part of the emerging field of digital therapeutics, that supports professionals to prescribe and refer patients to exercise appropriately, and people with long-term health conditions to safely increase their physical activity. It’s designed for up to 23 co-morbid physical and mental health conditions, including prevalent and serious non-communicable diseases (NCDs) such as obesity, cardiovascular disease, diabetes, hypertension, stroke, asthma, COPD, depression, anxiety, and stress. Fully regulated and bringing together behaviour change science with the latest clinical evidence and physical activity guidelines, it delivers safe, scalable, measurable health interventions that are medically proven, achievable for the end user, and quick and simple to prescribe and monitor. It also harnesses behaviour change support and rewards to engage patients in their prescription, drive adherence and support sustained physical activity. A smartphone app supports end users while a secure data portal allows the professional to monitor outcomes and adherence.